BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26425903)

  • 1. The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.
    MacVittie TJ; Bennett AW; Farese AM; Taylor-Howell C; Smith CP; Gibbs AM; Prado K; Jackson W
    Health Phys; 2015 Nov; 109(5):427-39. PubMed ID: 26425903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing.
    Farese AM; Bennett AW; Gibbs AM; Hankey KG; Prado K; Jackson W; MacVittie TJ
    Health Phys; 2019 Mar; 116(3):339-353. PubMed ID: 30281533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Time Course of Radiation-induced Lung Injury in a Nonhuman Primate Model of Partial-body Irradiation With Minimal Bone Marrow Sparing: Clinical and Radiographic Evidence and the Effect of Neupogen Administration.
    MacVittie TJ; Farese AM; Parker GA; Jackson W
    Health Phys; 2019 Mar; 116(3):366-382. PubMed ID: 30624350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman Primates.
    Hankey KG; Farese AM; Blaauw EC; Gibbs AM; Smith CP; Katz BP; Tong Y; Prado KL; MacVittie TJ
    Radiat Res; 2015 Jun; 183(6):643-55. PubMed ID: 26035709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Radiation-induced Lung Injury in the Non-human Primate: A Review and Comparison of Mortality and Co-morbidities Using Models of Partial-body Irradiation with Marginal Bone Marrow Sparing and Whole Thorax Lung Irradiation.
    MacVittie TJ; Farese AM; Parker GA; Bennett AW; Jackson WE
    Health Phys; 2020 Nov; 119(5):559-587. PubMed ID: 33009295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Nephropathy in a Nonhuman Primate Model of Partial-body Irradiation with Minimal Bone Marrow Sparing-Part 1: Acute and Chronic Kidney Injury and the Influence of Neupogen.
    Cohen EP; Hankey KG; Farese AM; Parker GA; Jones JW; Kane MA; Bennett A; MacVittie TJ
    Health Phys; 2019 Mar; 116(3):401-408. PubMed ID: 30608245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model.
    Zhong Y; Pouliot M; Downey AM; Mockbee C; Roychowdhury D; Wierzbicki W; Authier S
    Int J Radiat Biol; 2021; 97(sup1):S100-S116. PubMed ID: 32960660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of filgrastim to mitigate mortality following LD50/60 total-body irradiation is administration time-dependent.
    Farese AM; Brown CR; Smith CP; Gibbs AM; Katz BP; Johnson CS; Prado KL; MacVittie TJ
    Health Phys; 2014 Jan; 106(1):39-47. PubMed ID: 24276548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and functional impairment in the gut in a partial body irradiation minipig model of GI-ARS.
    Kaur A; Ten Have GAM; Hritzo B; Deutz NEP; Olsen C; Moroni M
    Int J Radiat Biol; 2020 Jan; 96(1):112-128. PubMed ID: 30475652
    [No Abstract]   [Full Text] [Related]  

  • 10. Rat Models of Partial-body Irradiation with Bone Marrow-sparing (Leg-out PBI) Designed for FDA Approval of Countermeasures for Mitigation of Acute and Delayed Injuries by Radiation.
    Fish BL; MacVittie TJ; Gao F; Narayanan J; Gasperetti T; Scholler D; Sheinin Y; Himburg HA; Hart B; Medhora M
    Health Phys; 2021 Oct; 121(4):419-433. PubMed ID: 34546222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filgrastim improves survival in lethally irradiated nonhuman primates.
    Farese AM; Cohen MV; Katz BP; Smith CP; Gibbs A; Cohen DM; MacVittie TJ
    Radiat Res; 2013 Jan; 179(1):89-100. PubMed ID: 23210705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hematopoietic Syndrome of the Acute Radiation Syndrome in Rhesus Macaques: A Systematic Review of the Lethal Dose Response Relationship.
    MacVittie TJ; Farese AM; Jackson W
    Health Phys; 2015 Nov; 109(5):342-66. PubMed ID: 26425897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Natural History of Acute Radiation-induced H-ARS and Concomitant Multi-organ Injury in the Non-human Primate: The MCART Experience.
    Farese AM; Booth C; Tudor GL; Cui W; Cohen EP; Parker GA; Hankey KG; MacVittie TJ
    Health Phys; 2021 Oct; 121(4):282-303. PubMed ID: 34546213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
    Singh VK; Hauer-Jensen M
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
    Singh VK; Kulkarni S; Fatanmi OO; Wise SY; Newman VL; Romaine PL; Hendrickson H; Gulani J; Ghosh SP; Kumar KS; Hauer-Jensen M
    Radiat Res; 2016 Mar; 185(3):285-98. PubMed ID: 26930378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.
    MacVittie TJ; Farese AM; Smith WG; Baum CM; Burton E; McKearn JP
    Blood; 2000 Feb; 95(3):837-45. PubMed ID: 10648394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation.
    MacVittie TJ; Bennett A; Booth C; Garofalo M; Tudor G; Ward A; Shea-Donohue T; Gelfond D; McFarland E; Jackson W; Lu W; Farese AM
    Health Phys; 2012 Oct; 103(4):427-53. PubMed ID: 22929471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques.
    Farese AM; Cohen MV; Stead RB; Jackson W; Macvittie TJ
    Radiat Res; 2012 Nov; 178(5):403-13. PubMed ID: 22991919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Abbreviated Filgrastim Schedule on Survival and Hematopoietic Recovery after Irradiation in Four Mouse Strains with Different Radiosensitivity.
    Satyamitra M; Kumar VP; Biswas S; Cary L; Dickson L; Venkataraman S; Ghosh SP
    Radiat Res; 2017 Jun; 187(6):659-671. PubMed ID: 28362168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.